The global dialysis market was valued at USD 104.23 billion in 2023. It is expected to reach USD 149.65 billion in 2032, growing at a CAGR of 5.10% over the forecast period (2024-32). The increasing incidence of chronic kidney diseases, attributed to factors such as aging populations, diabetes, hypertension, and lifestyle changes, drives the demand for dialysis treatment. As the prevalence of CKD rises globally, so does the need for dialysis services and equipment.
The kidney's primary function is to eliminate excess fluid and waste from circulation. Dialysis is used to carry out this operation when the kidneys are not functioning adequately. Artificial and natural semi-permeable membranes remove waste products like urea and creatinine from the blood. In contrast to peritoneal dialysis, which uses the peritoneum in the abdomen as a biological semi-permeable membrane, hemodialysis purifies the blood using an artificial membrane. Increases in the prevalence of end-stage renal diseases, an increase in the number of cases of diabetes and hypertension, and a spike in financing for the development of new technologies are the main reasons fueling the expansion of the dialysis industry.
Chronic kidney diseases (CKDs) are among the most common renal disorders, with a projected incidence of 22.2% among the global spread of kidney diseases. According to the organization, between 5.5 million and 10.5 million people with CKD need dialysis or a transplant. Additionally, people with CKDs are five to ten times more likely to pass away before developing end-stage kidney disease (ESKDs). Future demand for hemodialysis and peritoneal dialysis treatments is anticipated to rise due to the increased prevalence of CKDs and rising mortality rates.
Since the transplant technique is foreign to the human body, kidney transplantation involves a major operation, a donor match, and a lifetime regimen of immunosuppressant drugs to avoid bodily rejection against the organ. By raising the risk of diabetes, cancer, and severe infections, these medications may hurt the health of their patients. A patient with a history of cancer, dementia, extreme obesity, or drug or alcohol addiction cannot typically choose to have a kidney transplant. As a result, these characteristics make it less likely for individuals to select a kidney transplant. Contrarily, compared to transplants, dialysis treatments are often appropriate for most patients and require regular but relatively shorter treatment hours.
Dialysis is used to take the place of kidney function. When receiving dialysis access for the removal and purification of biological fluids, the closed vascular system within the body is in danger. One of the most frequent side effects of dialysis is an infection, which is harmful to the people receiving treatment. For instance, a 2018 study that used national registries from Denmark looked into the connection between patient mortality and the increased risk of bloodstream infection (BSI) associated with hemodialysis and peritoneal dialysis. A total of 2,646 people were assessed, and 366 later died after being diagnosed with BSI. The results also demonstrated an incremental link between patient dialysis modes and vascular access types.
Home hemodialysis (HHD) stands out as a better option than in-center hemodialysis due to its effectiveness and patient-centeredness (ICHD). Due to the rising acceptance of HHD in numerous nations, pharmaceutical companies are expected to invest in home dialysis education for patients and clinicians during the forecast period. The emergence of user-friendly operating systems like the NxStage System One machine for home dialysis and ostensible research determining improved outcomes of HHD relative to patients receiving ICHD is credited with this renaissance in HHD. It is projected that this change in customer preferences will present attractive business prospects for HHD, supporting the expansion of the dialysis market.
Some causes encouraging pharmaceutical corporations to create more advanced dialysis treatment equipment are rising healthcare spending and rising healthcare demand in emerging nations. Key market participants have adopted several methods to increase their geographic presence worldwide over the past ten years. For instance, Fresenius Medical Care began investing in tier 2 and tier 3 Chinese cities with a shortage of physicians and nurses by offering the locals reasonably priced goods. In order to establish a strong presence in the nation, the business bought a dialysis facility in Quanzhou in 2017.
| Study Period | 2020-2032 | CAGR | 5.23% |
| Historical Period | 2020-2022 | Forecast Period | 2024-2032 |
| Base Year | 2023 | Base Year Market Size | USD 104.23 billion |
| Forecast Year | 2032 | Forecast Year Market Size | USD 149.65 billion |
| Largest Market | Asia-Pacific | Fastest Growing Market | North America |
The global dialysis market is bifurcated into four regions, namely North America, Europe, Asia-Pacific, and LAMEA.
Asia-Pacific is the most significant shareholder in the global dialysis market and is expected to grow at a CAGR of 6.10% during the forecast period. The market for dialysis in Asia-Pacific is researched across Japan, China, Australia, India, South Korea, Taiwan, and the rest of the region. Due to its sizable population, numerous chronic and lifestyle diseases, and rapid rise in ESRD prevalence, Asia-Pacific delivers lucrative potential for dialysis players. Chronic and lifestyle diseases like hypertension, diabetes, chronic glomerulonephritis, and autoimmune diseases are also common in Asia-Pacific, resulting in poor treatment outcomes. These conditions are caused by low gross domestic products in developing countries, inadequate funding for healthcare, and a higher percentage of patients living below the poverty line.
North America is anticipated to grow at a CAGR of 3.80% generating USD 35,253.25 million during the forecast period. The region's dialysis market is anticipated to rise in the following years due to renal illnesses (mostly ESRD and CKD), increased public knowledge of home dialysis, and the region's well-established healthcare infrastructure. Additionally, the hospitalization rate for those with ESRD and CKD who receive dialysis has declined recently. A significant part of this was attributable to a surge in the knowledge of home dialysis treatments and modifications to regional legislation.
Europe is examined in five nations: Germany, France, the United Kingdom, Italy, Spain, and the rest of Europe. It is the second-largest market contributor to the global market because of the region's expanding patient population, which includes those with ESRD and CKD, high patient disposable income, stable healthcare infrastructure, and high spending income of patients. Due to a change in demographic trends among the European population, where the majority of people are getting older, it is projected that the population afflicted by chronic kidney illnesses and the prevalence of ESRD disease will increase significantly. The likelihood of losing normal renal function is highest in the senior population. Hence the number of kidney patients choosing dialysis is expected to rise.
It is anticipated that the dialysis market in LAMEA will grow slowly due to the region's lower socioeconomic position, limited access to necessary therapies, and lack of trained and experienced experts for dialysis treatment and procedures. In this region, there is a lack of knowledge on using hemodialysis and peritoneal dialysis for kidney-related disorders. Managing and paying for ESRD and CKD therapies are challenging in many Sub-Saharan African nations since dialysis requires expensive equipment and supplies. However, regional market participants have significantly invested in hemodialysis and peritoneal dialysis production.
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
The global dialysis market is segmented by type, product and service, and end-user.
Based on Type, the global market is bifurcated into hemodialysis and peritoneal dialysis.
The hemodialysis segment is the highest contributor to the market and is expected to grow at a CAGR of 5.01% during the forecast period. A filter is used in hemodialysis to filter the blood's waste materials and extra fluids. The patient's body is then refilled with the cleaned blood. Hemodialysis is typically performed in hospitals and dialysis facilities, while it is presently possible to perform it at home. The operation typically takes four hours to complete and is done thrice weekly. The main factors driving the market expansion of this sector are the rise in the number of dialysis facilities and technological developments in hemodialysis products. A broad population base and a high rate of hemodialysis adoption also contribute to the market's expansion.
In peritoneal dialysis, cleaning a patient's blood is carried out utilizing the abdominal lining. The stomach's lining, known as the peritoneum, is a natural filter to separate wastes like urea from the blood. Dialysate, a cleaning agent, is used to absorb the waste and remove it from the body. The development of more technologically advanced peritoneal dialysis products is anticipated to drive segment expansion. For instance, scientists at the Medical University of Vienna have created a brand-new peritoneal dialysis fluid that can shield abdominal cavity cells from any adverse effects of peritoneal dialyzes, such as peritonitis.
Based on Products and Services, the global market is bifurcated into equipment, consumables, dialysis drugs, and services.
The services segment owns the highest market share and is expected to grow at a CAGR of 4.90% during the forecast period. Many businesses that provide dialysis products also offer patient care. These businesses operate their dialysis facilities where patients can receive a range of dialysis services, including treatments for those who receive dialysis and laboratory services related to dialysis. As the vast majority of dialysis patients choose these services, the market growth for dialysis services has increased, making it the market's dominating category. The availability of skilled healthcare professionals in the centers contributes to the market expansion of dialysis services. Doctors' high-quality management and patient care also increase the demand for these services.
Numerous pieces of equipment are utilized during the dialysis process to increase the effectiveness of the therapy. Dialysis machines, water treatment systems, and other dialysis equipment are a few examples of frequently used dialysis supplies. The patient's blood is pumped through dialysis equipment, where various filters are employed to purify it. Systems for purifying water are used to prepare it for use in dialysis. The quality of the water used for dialysis should be high since contaminated water can harm the patient's health. Dialysis chairs and other analytical systems, such as body composition monitors, are other items used during dialysis.
Based on End-User, the global market is bifurcated into in-center dialysis and home dialysis.
In the dialysis market, hospitals and in-center dialysis centers are the dominant end users. This dominance is primarily driven by the higher frequency and volume of dialysis treatments conducted in these settings compared to home dialysis. Hospitals and in-center dialysis centers offer comprehensive care with access to specialized medical staff and equipment, ensuring high-quality treatment and immediate medical intervention if needed. Additionally, these centers often cater to patients who require more intensive care, such as those with complex comorbidities, which further boosts their demand.
On the other hand, home dialysis is gaining traction due to its convenience, cost-effectiveness, and improved quality of life for patients. However, it still faces challenges such as the need for patient and caregiver training, home modifications, and consistent medical monitoring. Despite these advantages, the infrastructure and medical oversight provided by hospitals and in-center dialysis centers continue to make them the preferred choice for dialysis treatment.
The automotive industry is critical to the economy's growth. However, during the second and third quarters of 2020, the COVID-19 outbreak impacted the whole automotive supply chain, affecting new car sales in FY 2020.
South America is most affected by COVID-19, with Brazil leading the way, followed by Ecuador, Chile, Peru, and Argentina. South America's government (SAM) has taken a number of steps to protect its citizens and stem the spread of COVID-19. South America is expected to have fewer export revenues as commodity prices fall and export volumes fall, particularly to China, Europe, and the United States, which are all significant trading partners. The manufacturing industry, especially automotive manufacturing, has been damaged by containment measures in various South American countries. Due to the pandemic, major automotive manufacturers have also temporarily halted manufacturing in the region as a cost-cutting move. Furthermore, the automobile disc brake industry has been significantly affected in 2020 due to a lack of raw materials and supply chain disruption.
The Automotive Brake System control module of a vehicle is meant to alert the driver with a warning light if the system fails. The module itself is rarely defective; instead, the sensors or the wiring to the sensors are frequently defective. The most typical cause of dysfunction is when the Automotive Brake System is contaminated with particles or metal shavings. There is no signal continuity when sensor wiring is destroyed. Brake fluid becomes contaminated in corrosive situations, and the hydraulic unit fails to function.
